Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance

  • Kim, Seung (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Koh, Hong (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine)
  • Received : 2015.04.09
  • Accepted : 2015.07.01
  • Published : 2015.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease mainly affecting the gastrointestinal tract. The incidence of the disease is rapidly increasing worldwide, and a number of patients are diagnosed during their childhood or adolescence. Aside from controlling the gastrointestinal symptoms, nutritional aspects such as growth, bone mineral density, anemia, micronutrient deficiency, hair loss, and diet should also be closely monitored and managed by the pediatric IBD team especially since the patients are in the development phase.

Keywords

References

  1. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. https://doi.org/10.1002/ibd.21493
  2. Oh SH, Kim KM. Current issues of pediatric inflammatory bowel disease in Korea. Korean J Pediatr 2014;57:465-71. https://doi.org/10.3345/kjp.2014.57.11.465
  3. Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, et al. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig Dis Sci 2010;55:1989-95. https://doi.org/10.1007/s10620-009-0963-5
  4. Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 2014;11:88-98. https://doi.org/10.1038/nrgastro.2013.240
  5. Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis 2013;45:89-94. https://doi.org/10.1016/j.dld.2012.09.005
  6. Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol 2012;46:581-9. https://doi.org/10.1097/MCG.0b013e318247c32f
  7. Song SM, Kim Y, Oh SH, Kim KM. Nutritional status and growth in Korean children with Crohn's disease: a single-center study. Gut Liver 2014;8:500-7. https://doi.org/10.5009/gnl13183
  8. Heuschkel R, Salvestrini C, Beattie RM, Hildebrand H, Walters T, Griffiths A. Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 2008; 14:839-49. https://doi.org/10.1002/ibd.20378
  9. Walters TD, Griffiths AM. Growth impairment in pediatric inflammatory bowel disease. New York: Springer, 2008:109.
  10. Gupta N, Lustig RH, Kohn MA, Vittinghoff E. Menarche in pediatric patients with Crohn's disease. Dig Dis Sci 2012;57:2975-81. https://doi.org/10.1007/s10620-012-2235-z
  11. DeBoer MD, Denson LA. Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains. J Pediatr 2013;163:17-22. https://doi.org/10.1016/j.jpeds.2013.02.010
  12. Altowati MA, Russell RK, Ahmed SF. Endocrine therapy for growth retardation in paediatric inflammatory bowel disease. Paediatr Drugs 2014;16:29-42. https://doi.org/10.1007/s40272-013-0046-0
  13. Targownik LE, Bernstein CN, Leslie WD. Risk factors and management of osteoporosis in inflammatory bowel disease. Curr Opin Gastroenterol 2014;30:168-74. https://doi.org/10.1097/MOG.0000000000000037
  14. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998;114:902-11. https://doi.org/10.1016/S0016-5085(98)70309-9
  15. Ghishan FK, Kiela PR. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2011;300:G191-201. https://doi.org/10.1152/ajpgi.00496.2010
  16. Kim HJ, Hong SJ, Jeon YW, Han JP, Han SH, Kang JH, et al. The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease. Clin Endosc 2013;46:71-6. https://doi.org/10.5946/ce.2013.46.1.71
  17. Rufo PA, Denson LA, Sylvester FA, Szigethy E, Sathya P, Lu Y, et al. Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. J Pediatr Gastroenterol Nutr 2012;55:93-108. https://doi.org/10.1097/MPG.0b013e31825959b8
  18. Schmidt S, Mellstrom D, Norjavaara E, Sundh V, Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:511-8. https://doi.org/10.1097/MPG.0b013e31825817a0
  19. Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis 2012;18:1961-81. https://doi.org/10.1002/ibd.22906
  20. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
  21. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13:1545-53. https://doi.org/10.1002/ibd.20285
  22. Gomollon F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009;15:4659-65. https://doi.org/10.3748/wjg.15.4659
  23. Filmann N, Rey J, Schneeweiss S, Ardizzone S, Bager P, Bergamaschi G, et al. Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis 2014;20:936-45. https://doi.org/10.1097/01.MIB.0000442728.74340.fd
  24. Rogler G, Vavricka S. Anemia in inflammatory bowel disease: an under-estimated problem? Front Med (Lausanne) 2015;1:58.
  25. Yakut M, Ustun Y, Kabacam G, Soykan I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 2010;21:320-3. https://doi.org/10.1016/j.ejim.2010.05.007
  26. Lindenbaum J. Drugs and vitamin B12 and folate metabolism. Curr Concepts Nutr 1983;12:73-87.
  27. Alkhouri RH, Hashmi H, Baker RD, Gelfond D, Baker SS. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;56:89-92. https://doi.org/10.1097/MPG.0b013e31826a105d
  28. Shah R, Abraham B, Hou J, Sellin J. Frequency and associated factors of hair loss among patients with inflammatory bowel disease. World J Gastroenterol 2015;21:229-32. https://doi.org/10.3748/wjg.v21.i1.229
  29. Patel KV, Farrant P, Sanderson JD, Irving PM. Hair loss in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1753-63. https://doi.org/10.1097/MIB.0b013e31828132de
  30. Ruemmele FM, Turner D. Differences in the management of pediatric and adult onset ulcerative colitis: lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis. J Crohns Colitis 2014;8:1-4. https://doi.org/10.1016/j.crohns.2013.10.006
  31. Suh HA, Kim SE, Jang JY, Kim BJ, Kim JS, Lee SY, et al. Efficacy of nutritional therapy in children with crohn disease. Korean J Pediatr Gastroenterol Nutr 2006;9:210-7.
  32. Day AS, Burgess L. Exclusive enteral nutrition and induction of remission of active Crohn's disease in children. Expert Rev Clin Immunol 2013;9:375-83. https://doi.org/10.1586/eci.13.12
  33. Kang Y, Kim S, Kim SY, Koh H. Effect of short-term partial enteral nutrition on the treatment of younger patients with severe Crohn's disease. Gut Liver 2015;9:87-93. https://doi.org/10.5009/gnl13345
  34. Hou JK, Lee D, Lewis J. Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol 2014;12:1592-600. https://doi.org/10.1016/j.cgh.2013.09.063
  35. Yamamoto T. Nutrition and diet in inflammatory bowel disease. Curr Opin Gastroenterol 2013;29:216-21. https://doi.org/10.1097/MOG.0b013e32835b9a40
  36. Lee J, Allen R, Ashley S, Becker S, Cummins P, Gbadamosi A, et al. British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adults. J Hum Nutr Diet 2014;27:207-18. https://doi.org/10.1111/jhn.12176

Cited by

  1. Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases—Promises, Perspectives, and Pitfalls vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/9346470
  2. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China vol.24, pp.9, 2015, https://doi.org/10.3748/wjg.v24.i9.1035
  3. Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study vol.68, pp.1, 2015, https://doi.org/10.1097/mpg.0000000000002119
  4. Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment? vol.77, pp.5, 2015, https://doi.org/10.4166/kjg.2021.067